Mission & Description
The Scleroderma Clinical Trials Consortium Inc, located in Boston, MA, is a nonprofit organization focused on advancing clinical research and trials for scleroderma, a complex autoimmune disease. With an annual revenue of $326K, the consortium aims to improve treatment options and outcomes for patients affected by this condition.
Official Records
| EIN | 04-3543489 |
| Subsection | 501(c)(3) |
| Classification | Public Charity |
| NTEE Code | H99 — Medical Research |
| Ruling Date | June 2001 |
| Revocation History | None |
Officers & Directors
No officer compensation data available.
Claim this profile
We're onboarding nonprofits from our waitlist. Join to be first in line for a verified badge, custom profile page, and a permanent SEO backlink — all free, forever.
Run this nonprofit? Your books could do themselves.
Holdings gives nonprofits full fund accounting from $25/mo — restricted funds, donation tracking, and board-ready reports. Plus free banking with 1.75% APY and up to $3M FDIC insurance through i3 Bank (Member FDIC).
Get started free